Chiraag Kulkarni
Stanford University
Appearances
- DateMay 19, 2024BACKGROUND: Primary sclerosing cholangitis (PSC) is a progressive, cholestatic liver disease without medical cure, that confers a significantly elevated risk of malignancy, acute cholangitis and cirrhosis. Approximately 2-7% of patients with inflammatory bowel disease (IBD) will develop PSC…
Presenter
Stanford University - DateMay 5, 2025This abstract based session will explore the outcomes of colonoscopy screening and surveillance, focusing on various factors that influence detection and adherence…
Moderators
Stanford UniversityMassachusetts General Hospital